68Ga-PSMA与18F-FDG PET/CT在肾细胞癌转移及疗效评估中的互补作用
本文报告一例透明细胞肾细胞癌病例,PET/CT显示转移灶对FDG和PSMA的摄取存在互补性,体现肿瘤异质性。非FDG高摄取肺和骨转移灶有PSMA摄取,而宫颈和腋窝淋巴结转移灶相反,股外侧肌转移灶两者均阳性。疗效评估发现混合反应,提示68Ga-PSMA和18F-FDG PET/CT可能在透明细胞肾细胞癌转移准确显示和疗效评估中具有互补作用。
要点
- 透明细胞肾细胞癌转移灶对FDG和PSMA摄取存在互补性,体现肿瘤异质性。
- 肺和骨转移灶非FDG高摄取但有PSMA摄取,宫颈和腋窝淋巴结转移灶相反。
- 股外侧肌转移灶(不常见部位)显示PSMA和FDG均阳性,疗效评估为混合反应。
核心结论
- 68Ga-PSMA和18F-FDG PET/CT可能在透明细胞肾细胞癌转移准确显示和疗效评估中具有互补作用。
研究设计与样本
- 本文为病例报告,报告一例透明细胞肾细胞癌患者的PET/CT表现。
主要发现
- 肺和骨转移灶无FDG高摄取但有PSMA摄取,宫颈和腋窝淋巴结转移灶则相反。
- 股外侧肌转移灶(不常见转移部位)显示PSMA和FDG均阳性。
- 疗效评估中检测到混合反应。
临床怎么用
- 在透明细胞肾细胞癌中可考虑联合68Ga-PSMA和18F-FDG PET/CT以更准确显示转移灶和评估疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present a case of clear cell renal cell carcinoma, which demonstrates complementary FDG and prostate-specific membrane antigen (PSMA) uptake on metastases in PET/CT, as an example of tumor heterogeneity. The patient had non-FDG-avid lung and bone metastases with PSMA uptake, whereas metastatic cervical and axillary lymph nodes showed vice versa, and skeletal muscle metastasis to vastus lateralis, which is an unusual region for metastasis, showed both PSMA and FDG positivity. In response assessment, mix response was detected. It seems that 68Ga-PSMA and 18F-FDG may have a complementary role in demonstration of metastasis accurately and assessment of treatment response in clear cell renal cell carcinoma.
引用
- Has Simsek D, Civan C, Erdem S, et al. Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma. Clin Nucl Med. 2021. PMID: 33782292. doi:10.1097/RLU.0000000000003590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。